Crossmark

Revealing the active ingredients and mechanisms of Xiatianwu against hepatocellular carcinoma: a study based on network pharmacology and bioinformatics

Crossref DOI link: https://doi.org/10.1007/s00210-024-03278-2

Published Online: 2024-07-25

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Hui https://orcid.org/0000-0003-3653-1789
Zhang, Weina

Li, Liling

Wang, Hong

Jiang, Honglin

Li, Wenna

Huang, Jinchang

Wan, Yuxiang
Funding

Funding for this research was provided by:

the Natural Science Foundation of China (82074545, 82205292)

Project of Beijing University of Chinese Medicine (2022-JYB-JBZR-042)

Project of the China Association of Chinese Medicine (CACM-2022-QNRC2-B02)
License Information

Text and Data Mining valid from 2024-07-25

Version of Record valid from 2024-07-25
More Information

Article History

Received: 26 May 2024

Accepted: 2 July 2024

First Online: 25 July 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below